Our data indicated that mammary tumours expressing low or high NCL levels had different clinical characteristics (i.e., tumour grade and ER/PR hormonal status), supporting association with distinct NCL-dependent functions. The gene discussed is NUCLEOLIN; the disease is breast cancer.